Abstract:To identify tumor suppressor genes (TSGs) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection. ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC). We explored epigenetic alterations in this gene in ccRCC and analyzed possible clinicopathological associations. We examined ADAMTS18 gene expression and methylation by semi-quantitative reverse transcription PCR (RT-PCR) and methylation-specific polymerase chain reaction (MSP) in 5 ccRCC-derived cell lines before and after treatment with 5-aza-2'-deoxycytidine (5-AzaC). MSP was further performed for 101 ccRCC primary tumors and 20 adjacent normal tissues. Some cell lines and specimens were examined by subsequent bisulfite genomic sequencing (BGS) and real-time PCR. Further, we analyzed the relationship between the ADAMTS18 gene methylation and clinicopathological features, including short-term disease-free survival (DFS), in patients with ccRCC. ADAMTS18 down-regulation and hypermethylation were detected in the ccRCC-derived cell lines using RT-PCR and MSP. Treatment with 5-AzaC reversed the hypermethylation of the ADAMTS18 gene and restored its expression. Hypermethylation was further detected in 44 of 101 (43.6%) primary tumors and 3 of 20 (15.0%) adjacent normal tissues. However, a significant difference between both groups was observed (p = 0.02). BGS analysis and real-time PCR were subsequently performed to confirm the results of RT-PCR and MSP. Furthermore, the methylation status of ADAMTS18 was not significantly associated with gender, age, location, tumor diameter, pathological stage, nuclear grade or short-term DFS in patients with ccRCC (p > 0.05). The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a TSG in ccRCC. We conclude that ADAMTS18 gene hypermethylation may be involved in the tumorigenesis of ccRCC and may serve as a novel biomarker for this disease.

Methylation‑associated Inactivation of LATS1 and Its Effect on Demethylation or Overexpression on YAP and Cell Biological Function in Human Renal Cell Carcinoma.

Promoter Hypermethylation-Mediated Down-Regulation of LATS1 and LATS2 in Human Astrocytoma

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

Epigenetic Inactivation of the Candidate Tumor Suppressor Gene ASC/TMS1 in Human Renal Cell Carcinoma and Its Role As a Potential Therapeutic Target

Expression and Significance of Yes-associated Protein and Large Tumor Suppressor Gene 1 in Renal Clear Cell Carcinoma

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

T851I Mutation of Human Large Tumor Suppressor 1 Disrupts Its Kinase Activity and Tumor-Suppressor Functions.

LATS1 K751 Acetylation Blocks Activation of Hippo Signalling and Switches LATS1 from a Tumor Suppressor to an Oncoprotein

Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas.

The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression

PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation

Tumor Suppressor LKB1 Inhibits Both the Mrna Expression and the Amplification of Hterc by the Phosphorylation of YAP in Lung Cancer Cells

LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.

Hypermethylation of BRM Promoter Plays Oncogenic Roles in Development of Clear Cell Renal Cell Carcinoma

LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis.

Hypermethylation Of The 16q23.1 Tumor Suppressor Gene Adamts18 In Clear Cell Renal Cell Carcinoma

DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway

Knockdown of Yes-Associated Protein Inhibits Proliferation and Downregulates Large Tumor Suppressor 1 Expression in MHCC97H Human Hepatocellular Carcinoma Cells

Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma

[Aberrant Methylation of Tumor Suppressor Genes in Renal Cell Carcinoma].